~~<i id='3A162C1801'><strike id='3A162C1801'><tt id='3A162C1801'><pre id='3A162C1801'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

WSS

Notifications
- knowledge
George Santos makes 1st court appearance after pleading not guilty to 13 counts
log on

explore

focus

author：entertainment 2025-09-29 18:31:23 - browse：2

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

focus

leisure time

Wikipedia

explore

entertainment

hotspot

Abiomed,whichwasboughtbyJohnson&Johnsonlatelastyearfor$16.6billion,sellsdevicesforheartfailurepa

WSS

CEOs share strategies for surviving biotech slump

Medicare reduced heart disease by changing how it pays doctors

Explaining an after

Will Ozempic

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

STAT Summit: Biotech founders on deal

explore

focus

Featured Speakers

focus

In Memoriam: Notable people who died in 2023

Inari Medical to buy amputation prevention company LimFlow

Cancer drug shortages should be causing more outrage

CEOs share strategies for surviving biotech slump

Psychedelics group wrestles with new pharma identity

Hospital price transparency does save money, advocate argues

Heart attack and stroke risk calculators need revising

Medicare reduced heart disease by changing how it pays doctors

Virginia high school admissions case could be legal follow

The health care issue Democrats can’t solve: hospital reform

leisure time

Gene therapy’s promise and the high cost of hope

The explosion of genetic testing requires a new approach

Life sciences investors close nearly $6 billion in new funds

Coloradans with cystic fibrosis could lose access to Trikafta

Coloradans with cystic fibrosis could lose access to Trikafta

Medicare reduced heart disease by changing how it pays doctors

Wikipedia

explore

entertainment

hotspot